PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 9, 2005Arteriosclerosis Thrombosis and Vascular Biology211 citationsOpen Access

Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus

View Full Paper
IFIrlando Andrade FerreiraAMAstrid I.M. MockingMFMarion A.H. Feijge

Structured PICO

Does insulin stimulation inhibit platelet activity in patients with type 2 diabetes mellitus compared to healthy subjects?

P
Population
Patients with type 2 diabetes mellitus (DM2) and healthy subjects
I
Intervention
Insulin stimulation (ex vivo)
C
Comparator
Platelets from healthy subjects
O
Outcome
Platelet responsiveness to insulin (measured by Ser473 phosphorylation of protein kinase B, adhesion, aggregation, and procoagulant activity)surrogate

Platelets from patients with type 2 diabetes mellitus lose responsiveness to insulin, which may explain their hyperactivity and increased thrombotic risk.

Abstract

OBJECTIVE: ADP-induced P2y12 signaling is crucial for formation and stabilization of an arterial thrombus. We demonstrated recently in platelets from healthy subjects that insulin interferes with Ca2+ increases induced by ADP-P2y1 contact through blockade of the G-protein Gi, and thereby with P2y12-mediated suppression of cAMP. METHODS AND RESULTS: Here we show in patients with type 2 diabetes mellitus (DM2) that platelets have lost responsiveness to insulin leading to increased adhesion, aggregation, and procoagulant activity on contact with collagen. Using Ser473 phosphorylation of protein kinase B as output for insulin signaling, a 2-fold increase is found in insulin-stimulated normal platelets, but in DM platelets there is no significant response. In addition, DM2 platelets show increased P2y12-mediated suppression of cAMP and decreased P2y12 inhibition by the receptor antagonist AR-C69931MX. CONCLUSIONS: The loss of responsiveness to insulin together with increased signaling through P2y12 might explain the hyperactivity of platelets in patients with DM2.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ferreira et al. (2005) studied this question.

synapsesocial.com/papers/6a7dea78f3499a80f78c9cd9https://doi.org/10.1161/01.atv.0000199519.37089.a0
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Platelet-collagen interaction: is GPVI the central receptor?2003 · 1,154 citations
  2. 2Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine1992 · 346 citations
  3. 3Atherosclerosis — An Inflammatory Disease1999 · 21,779 citations
  4. 4Role of ADP Receptor P2Y12in Platelet Adhesion and Thrombus Formation in Flowing Blood2002 · 125 citations
  5. 5Phosphopleckstrin Inhibits Gβγ-activable Platelet Phosphatidylinositol-4,5-bisphosphate 3-Kinase1996 · 43 citations